The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) may have pushed notably higher on Monday, but not all shares on the local market were so lucky. In fact, a few shares sank to 52-week lows or worse. Three that caught my eye are listed below, is this a buying opportunity? The Amaysim Australia Ltd (ASX: AYS) share price sank to an all-time low of 75 cents on Monday. The low-cost telco operator has come under significant selling pressure since the release of a weak half-year result which revealed declines in average revenue per user. In addition to this, the arrival of…
You can continue reading this story now by entering your email below
The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) may have pushed notably higher on Monday, but not all shares on the local market were so lucky.
In fact, a few shares sank to 52-week lows or worse. Three that caught my eye are listed below, is this a buying opportunity?
The Amaysim Australia Ltd (ASX: AYS) share price sank to an all-time low of 75 cents on Monday. The low-cost telco operator has come under significant selling pressure since the release of a weak half-year result which revealed declines in average revenue per user. In addition to this, the arrival of TPG Telecom Ltd (ASX: TPM) in the space with its aggressively priced mobile plans is being seen by investors as a major threat to the Amaysim business model. While at this price it might be an attractive takeover option for one of the larger telco players, I plan to stay clear of the company.
The Ramsay Health Care Limited (ASX: RHC) share price fell to a two-year low of $59.80 yesterday. Like Amaysim, this private hospital operator’s shares came under pressure following the release of a disappointing half-year update. That update revealed significant weakness in its UK and France operations, offsetting the solid performance of its local operations. But with private hospital coverage on a sharp decline in Australia, I’m not convinced its Australian hospitals will perform as well in the second-half and in FY 2019. Especially after rival Healthscope Ltd (ASX: HSO) warned that it was experiencing weaker than expected trading conditions.
The Star Entertainment Group Ltd (ASX: SGR) share price touched on a 52-week low of $4.84 on Monday. The casino and resort operator’s shares have come under fire since the release of a trading update last week. Despite the update revealing that total normalised gross revenue is 16.4% higher so far in the second-half compared to the prior corresponding period, this was slightly below expectations. One positive, however, was the rise in VIP gaming and the low win rate being experienced by VIPs. With the majority of brokers positive on Star Entertainment and its shares changing hands at these low levels, I think it could be worth a closer look.
But only if you already own these stellar growth shares that I expect to provide market-beating returns over the next couple of years at least.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended TPG Telecom Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.